Product Information
OXYBUTYNIN CL ER 5 MG TABLET is a generic product labeled by Accord Healthcare Inc., priced at $0.0896 per EA under NDC 16729031701. Its NADAC has been published 491 times since Dec 28, 2016.
FDA first approved this application on Feb 29, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729031701
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
5/20/2026
Active Ingredients
OXYBUTYNIN CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207138FDA Approved
2/29/2016
TE Code
AB
On Market Since
12/14/2016
Pharmacological Classes
Price Statistics
The NADAC for OXYBUTYNIN CL ER 5 MG TABLET has been published 491 times since Dec 28, 2016, and over the history we have for it it has declined 87.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0896 per EA |
|---|---|
| All-time high | $0.7230 (Jan 11, 2017) |
| All-time low | $0.0765 (Nov 20, 2024) |
| 52-week high | $0.0990 |
| 52-week low | $0.0894 |
| Median price | $0.1702 |
| Average price | $0.2421 |
| Largest weekly change | +35.7% (Jun 19, 2024) |
| Weeks tracked | 491 |
| Tracking since | Dec 28, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
-0.8%
1Y
-8.9%
3Y
-8.0%
5Y
-45.8%
All
-87.6%
Last surveyed May 20, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 47% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OXYBUTYNIN CL ER 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OXYBUTYNIN CL ER 5 MG TABLET, manufactured by Accord Healthcare Inc., is $0.0896 per EA (NDC 16729031701), effective May 20, 2026.
How has the price of OXYBUTYNIN CL ER 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for OXYBUTYNIN CL ER 5 MG TABLET has declined 87.6%. It has been tracked across 491 weekly CMS publications since Dec 28, 2016.
What are the highest and lowest recorded NADAC prices for OXYBUTYNIN CL ER 5 MG TABLET?
Since Dec 28, 2016, the NADAC for OXYBUTYNIN CL ER 5 MG TABLET has ranged from a low of $0.0765 (Nov 20, 2024) to a high of $0.7230 (Jan 11, 2017), with a median of $0.1702 per EA.
Are there cheaper alternatives to OXYBUTYNIN CL ER 5 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OXYBUTYNIN 5 MG TABLET, is $0.0473 per EA — about 47% below OXYBUTYNIN CL ER 5 MG TABLET.
Who manufactures OXYBUTYNIN CL ER 5 MG TABLET?
OXYBUTYNIN CL ER 5 MG TABLET (NDC 16729031701) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.